BPC-157: Why Your Biohack Might Be a Regulatory Minefield
Smart founders chasing an edge often encounter BPC-157. This episode exposes its murky science, uncertain safety, and complex regulatory shell game.
Peptides: The Science, Uses & Safety | Dr. Abud Bakri
With Andrew Huberman, Dr. Abud Bakri · Sunday, June 7, 2026
This episode features Andrew Huberman and Dr. Abud Bakri, an internal medicine physician, in a masterclass discussion on peptides. They explore various categories of peptides, including FDA-approved GLP-1 agonists and non-FDA approved compounds like BPC-157, pinealon (EDR), GHK-Cu, and thymus peptides. The conversation delves into the science, mechanisms, safety profiles, anecdotal uses, and complex regulatory landscape surrounding these compounds, highlighting sourcing challenges and the ethical dilemmas clinicians face.
Key takeaways
- BPC-157, a peptide touted for healing, has no identified specific receptor, meaning its core mechanism is still a scientific mystery. This isn't just a detail; it's a gaping hole in understanding how it truly works. Read more →
- Beware Hidden Markups: Some doctors may prescribe GLP-1 agonists like Ozempic at $1,500/month, while a compounded version from another clinic could cost as little as $300. This disparity often hides clinician profit, making your choice an ethical and financial one. Read more →
- Somatopause is real: Around your 30s, natural growth hormone (GH) production drops significantly, a phase called somatopause, impacting recovery and vitality. Read more →
- Almost all active pharmaceutical ingredients (APIs) for peptides originate in China. There are no American-made peptides; they are only finished here, a fact Bakri confirmed directly. Read more →
5 articles from this episode
GLP-1s: The Hidden Costs, Ethical Traps, and Brain Unknowns
GLP-1 drugs promise weight loss, but Huberman and Bakri reveal shocking costs, ethical clinician profit, and critical long-term brain risks for founders. Don't leap before you look.
Growth Hormone Secretagogues: Muscle, Recovery, and a Hidden Risk?
GH secretagogues like MK677 promise muscle and recovery, but Huberman Lab reveals a stark trade-off: insulin sensitivity and cancer risk.
Peptide Supply Chain: Why Your 'Research Only' Vial Is a Minefield
Andrew Huberman and Dr. Abud Bakri expose the murky peptide market, from Chinese APIs to dangerous 'research only' vials. Founders, know your supply chain.
Your Thymus Gland Died at Puberty: What Now?
The thymus, vital for immunity, shrivels post-puberty. Learn how peptides like Thymosin Alpha 1 offer a path to regenerate it and boost resilience.
More Huberman Lab episodes
- Essentials: Genes & the Inheritance of Memories Across Generations | Dr. Oded RechaviSep 13 · 3 articles
- How Mitochondria Control Your Metabolism | Dr. Jared RutterSep 13 · 6 articles
- How to Accelerate Learning & Improve Education | Joe LiemandtSep 6 · 4 articles
- Essentials: Use Sleep to Enhance Learning, Memory & Emotional State | Dr. Gina PoeSep 6 · 5 articles